Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 18,76118,780 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Eco-evolutionary drivers of clonal dynamics during UV-induced skin carcinogenesis (PQ3)
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

ABSTRACT Cancers have readily-defined characteristics often referred to as “hallmarks”. Nevertheless, the question of how the sequence of cancer development progresses -- from norm...

$6.08M
USD
Completed NON-SBIR/STTR RPGS
Structure-activity relationships governing mammalian SWI/SNF chromatin remodeling activity as a function of chromatin state
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

PROJECT SUMMARY Recent whole-exome sequencing studies in human cancer and neurodevelopmental disorders have unmasked frequent mutations in genes encoding chromatin regulatory prote...

$6.56M
USD
Completed NON-SBIR/STTR RPGS
FEN1-Nuclease-Targeted Therapy for Ewing Sarcoma
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2021 – 2026

PROJECT SUMMARY Ewing Sarcoma Family of Tumors (ESFT) are bone and soft tissue cancers that affect children and adolescents. Surgery, radiation and multi-agent chemotherapy have im...

$5.93M
USD
Completed NON-SBIR/STTR RPGS
Targeting Systems Vulnerabilities in the Gαq/GNAQ Oncogenic Signaling Circuitry: New Precision Therapies for Uveal Melanoma
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2021 – 2026

Targeting Systems Vulnerabilities in the Gαq/GNAQ Oncogenic Signaling Circuitry: New Precision Therapies for Uveal Melanoma G protein-coupled receptors (GPCRs) represent the larges...

$5.03M
USD
Completed NON-SBIR/STTR RPGS
Role of Transcription Factor ADP-ribosylation in Breast Cancer Biology
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2026

Project Summary/Abstract The molecular heterogeneity of cancers poses a major hurdle for treatment and drug discovery efforts. Previous studies have addressed this challenge by cha...

$3.82M
USD
Completed NON-SBIR/STTR RPGS
Roles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

PROJECT SUMMARY Follicular lymphoma (FL) and diffuse large B cell lymphoma (DLBCL) are the most common germinal center (GC)- derived Non-Hodgkin B cell lymphomas (BCLs). Although i...

$4.31M
USD
Completed NON-SBIR/STTR RPGS
Developing and Testing a Digital Toolkit to Improve Colorectal Cancer Screening Rates in Federally Qualified Health Centers
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Colorectal cancer (CRC) is a leading cause of cancer death in the United States. National guidelines recommend that average risk people receive regular CRC...

$6.07M
USD
Completed NON-SBIR/STTR RPGS
HER2-mediated delivery of cytotoxic agents in solid tumors
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2025

PROJECT SUMMARY ERBB2/HER2 is a receptor tyrosine kinase (RTK) that is amplified/overexpressed in 15-20% of breast and gastroesophageal cancers, for which anti-HER2 therapy is now...

$5.58M
USD
Completed NON-SBIR/STTR RPGS
Investigating the roles of extracellular cGAMP and harnessing it for cancer treatment
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

PROJECT SUMMARY The goal of cancer immunotherapy is to awaken the body’s anti-tumoral immune response to fight against all cancers in all patients. Our lab recently identified a ke...

$4.76M
USD
Completed NON-SBIR/STTR RPGS
Optimizing Therapeutic STING Agonism in Triple Negative Breast Cancer
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

PROJECT SUMMARY Despite the therapeutic promise of STING agonists in cancer, first in human studies have been hampered by lack of precision therapy and issues with drug delivery. M...

$3.87M
USD
Completed NON-SBIR/STTR RPGS
Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity
NATIONAL CANCER INSTITUTE Ohio State University United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Chemotherapy induced peripheral neuropathy is a common dose-limiting toxicity that can reduce therapeutic effectiveness and impact quality of life for canc...

$3.45M
USD
Completed NON-SBIR/STTR RPGS
A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

SUMMARY Surgical resection is curative in hepatocellular carcinoma (HCC). Unfortunately, surgical cases often suffer from early recurrence (up to 50% in two years), which leads to...

$5.9M
USD
Completed NON-SBIR/STTR RPGS
Gain-of-function mutant p53 and metabolic reprogramming in colorectal cancer
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2021 – 2026

Tumor suppressor p53 plays a central role in tumor prevention. p53 is frequently mutated in human cancer, including colorectal cancer (CRC). Many mutant p53 (mutp53) proteins not o...

$4.37M
USD
Completed NON-SBIR/STTR RPGS
A Multi-pronged Computational Approach to Advance Kinase Drug Discovery
NATIONAL CANCER INSTITUTE University of Maryland Baltimore United States 2021 – 2025

Project Summary/Abstract In recent years, computing speed has exponentially increased; however, the potential of computational ap- proaches to accelerate drug discovery has not bee...

$3.34M
USD
Completed NON-SBIR/STTR RPGS
Epigenetic Control and Genome Organization
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

OVERALL PROGRAM SUMMARY Gary Stein and Janet Stein, Program Directors Our Program Project is a thematically, experimentally and operationally integrated multidisciplinary team appr...

$16.79M
USD
Completed NON-SBIR/STTR RPGS
Project 1: Mitotic Gene Bookmarking as an Epigenetic Mechanism to Maintain the Mammary Epithelial Phenotype
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

PROJECT 1 | SUMMARY Mechanisms underlying the epithelial to mesenchymal transition (EMT)—a normal developmental process and an early event at the onset of epithelium-derived cancer...

Completed NON-SBIR/STTR RPGS
Project 2: Bromodomains as Epigenetic Modulators of Endocrine Responsiveness in ER+ Breast Cancer
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

PROJECT 2: SUMMARY Breast cancer (BCa) ranks among the leading causes of cancer death in women worldwide. Estrogen Receptor alpha positive tumors (ER+) are the most common subtype...

Completed NON-SBIR/STTR RPGS
Project 3: MANCR Mediates Epigenetic Mechanisms for Survival of Advanced Breast Cancer
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

SUMMARY Long non-coding RNAs (lncRNAs) are epigenetic regulators of the chromatin organization supporting cancer cell activities. There is a gap in the literature identifying the c...

Completed NON-SBIR/STTR RPGS
Administration and Coordination Core
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

SUMMARY/ABSTRACT Administration and Coordination Core Gary Stein, Core Leader; Janet Stein, Co-Leader The Administration and Coordination Core will provide leadership, and administ...

Completed NON-SBIR/STTR RPGS
Experimental Integration, Design and Analysis Core
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

Summary: Experimental Integration, Design and Analysis Core The Experimental Integration, Design, and Analysis (EIDA) Core is an essential component of the program project that is...